Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-018-4813-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Letter About: Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Journal of General Internal Medicine
Internal Medicine
2019English

Noninferiority Trial Design and Analysis With an Ordered Three-Level Categorical Endpoint

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2009English

Outcome Assessments in Clinical Trials of Cryptococcal Meningitis: Considerations on Use of Early Fungicidal Activity as a Potential Surrogate Endpoint for All-Cause Mortality

Current Treatment Options in Infectious Diseases
2014English

Statistical Methods in Recent HIV Noninferiority Trials: Reanalysis of 11 Trials

PLoS ONE
Multidisciplinary
2011English

Non-Invasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials

Hepatology
MedicineHepatology
2018English

Problematic Internet Use: An Overview

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2010English

Inappropriate Data and Measures Lead to Questionable Conclusions

JAMA Psychiatry
MedicinePsychiatryMental Health
2013English

Problematic Use in Context

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2010English

Robust Designs in Noninferiority Three-Arm Clinical Trials With Presence of Heteroscedasticity

Statistics in Biopharmaceutical Research
StatisticsProbabilityPharmaceutical Science
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy